Chemoinformaics analysis of 2-Methyl-2-(4-methyl-3-cyclohexen-1-yl)oxirane
Molecular Weight | 152.237 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
Exact Molecular Weight | 152.12 | nRing | 2 |
Solubility: LogS | -3.408 | nHRing | 1 |
Solubility: LogP | 3.489 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 17.7873 |
QED | 0.415 |
Synth | 3.713 |
Natural Product Likeliness | 3.075 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.404 |
MDCK | 0.0000243 |
BBB | 0.362 |
PPB | 0.928724 |
VDSS | 1.829 |
FU | 0.0566557 |
CYP1A2-inh | 0.518 |
CYP1A2-sub | 0.33 |
CYP2c19-inh | 0.208 |
CYP2c19-sub | 0.85 |
CYP2c9-inh | 0.069 |
CYP2c9-sub | 0.384 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.468 |
CYP3a4-inh | 0.069 |
CYP3a4-sub | 0.264 |
CL | 16.569 |
T12 | 0.308 |
hERG | 0.014 |
Ames | 0.02 |
ROA | 0.021 |
SkinSen | 0.787 |
Carcinogencity | 0.865 |
EI | 0.952 |
Respiratory | 0.07 |
NR-Aromatase | 0.018 |
Antiviral | No |
Prediction | 0.945709 |